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ABSTRACT
Background: Laparoscopic adrenalectomy is accepted by
many as the standard of care for the majority of adrenal
masses less than 8 cm. The question exists whether lapa-
roscopic removal of metastatic lesions to the adrenal is
more difficult than laparoscopic removal of primary adre-
nal lesions.
Methods: We performed a retrospective analysis of all
laparoscopic adrenalectomies performed at a single insti-
tution from 1998 to 2001, comparing laparoscopic adre-
nalectomies for primary lesions of the adrenal gland ver-
sus isolated metastatic lesions to the adrenal gland.
Results: Fourteen laparoscopic adrenalectomies were at-
tempted, 10 for primary disease and 4 for metastatic dis-
ease. All 10 laparoscopic procedures were completed suc-
cessfully for primary disease (average operative time218
minutes, average tumor size4 cm, median hospital
stay2 days). Only one of the 4 laparoscopic adrenalec-
tomies for metastatic disease was completed successfully
(average operative time332 minutes, average tumor
size7.3 cm, median hospital stay2 days). No major
complications occurred in either group.
Conclusions: We feel laparoscopic adrenalectomy is the
preferred approach for primary adrenal masses less than 8
cm. Based on our experience and a review of the litera-
ture, isolated metastatic lesions to the adrenal gland ap-
pear less amenable to laparoscopic removal than do pri-
mary lesions of the same size.
Key Words: Laparoscopy, Adrenalectomy, Adrenal me-
tastasis.
INTRODUCTION
Surgery of the adrenal gland has undergone a revolution
over the last decade. Before the 1990s, removal of the
adrenal gland required an open incision. Because the
adrenal gland is a small, friable structure, and is located
high in the retroperitoneum, a large abdominal or flank
incision was generally required.1,2 This surgery necessi-
tated a long postoperative course. Although the posterior
approach decreased postoperative morbidity, this incision
often did not give sufficient exposure, especially for larger
masses.2 Since Gagner et al3 first described laparoscopic
adrenalectomy in 1992, laparoscopic adrenalectomy has
gained widespread acceptance for a variety of indica-
tions.4 As surgeons become more adept and technology
improves, the indications for minimally invasive surgery
for adrenal diseases continues to expand.
As imaging modalities improve and more incidental adre-
nal masses are found, the indication for laparoscopic adre-
nalectomies increases.1,5,6 Management is based on pa-
tient age, biochemical activity, size, and imaging
characteristics. Laparoscopic adrenalectomy has proven to
be an excellent procedure for most cases of adrenal dis-
ease with decreased morbidity, blood loss, and hospital
stay.5
While the evolution of laparoscopic adrenalectomy is un-
derway, a more quiet change of thought has taken place
regarding patients with isolated metastasis to the adrenal
gland. Formerly, these patients were treated palliatively
and considered unresectable. However, over the last 15
years, several small studies7 have reported a modest in-
crease in survival from aggressive surgical removal of
these isolated metastases. Autopsy series demonstrate me-
tastasis within the adrenal gland from renal cell carcinoma
and bronchogenic carcinoma to be 10% and 36%, respec-
tively.8 The development of computed tomography (CT)
has increased the number of patients discovered to have
metastatic lesions to the adrenal gland, both synchronous
and metachronous. The more commonly reported sites of
origin in the literature for these tumors include renal cell,
lung, melanoma, colorectal, thyroid, hepatocellular, and
gastric carcinoma.7,9–12
As laparoscopic indications expand and surgical removal
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SCIENTIFIC PAPERof the adrenal gland for isolated metastatic disease be-
comes more acceptable, a few case reports and small case
series4,9,11,13,14 have recently reported the use of laparos-
copy for metastasis to the adrenal gland. Is laparoscopic
surgery a safe and effective method for this highly select
group of patients? If so, should there be different criteria
for selecting these patients for laparoscopic adrenalec-
tomy versus patients with benign disease? We retrospec-
tively compared laparoscopic adrenalectomy for primary
tumors versus laparoscopic adrenalectomy for metastatic
disease at a single center over a 4-year period.
METHODS
A retrospective analysis of all laparoscopic adrenalecto-
mies attempted at a single institution was performed. All
patients underwent preoperative CT or magnetic reso-
nance imaging (MRI) scanning, or both, and had a bio-
chemical evaluation consisting of at least a 24-hour urine
collection for cortisol, 18-hydroxycortisol, aldosterone,
norepinephrine, epinephrine, dopamine, metanephrine,
normetanephrine, and vanillylmandelic acid. Additional
biochemical evaluations, such as renin levels, adrenal vein
sampling, glucagon stimulations, and others, were per-
formed as indicated. Preoperative demonstration of inva-
sive extraadrenal pathology was an absolute contraindi-
cation for surgery. Procedures were performed via a
transperitoneal or retroperitoneal approach. Operative,
anesthesia, pathology, and radiology notes were re-
viewed. Patients’ age, clinical presentation, radiographic
size and side of the lesion, history of previous abdominal
surgery, surgical approach, intraoperative course and
time, blood loss, hospital course, postoperative pain med-
ications used, complications, and final pathology were
recorded. Patients were separated into 2 groups, I and II.
Group I underwent laparoscopic adrenalectomy for pri-
mary disease, and Group II underwent laparoscopic ad-
renalectomy for metastatic disease.
RESULTS
Fourteen laparoscopic adrenalectomies were attempted in
13 patients, 10 for primary disease in Group I and 4 for
metastatic disease in Group II. Group I comprised 10
patients, and Group II comprised 3, with one patient
undergoing bilateral adrenalectomy. All 10 laparoscopic
procedures were completed successfully for primary dis-
ease with an average tumor size of 4 cm, average opera-
tive time of 218 minutes, blood loss of 153 mL, and a
median hospital stay of 2 days. Two minor (new onset
atrial fibrillation and postoperative hypokalemia) but no
major complications occurred (Table 1).
Table 1.
Group I. Laparoscopic Adrenalectomy for Primary Disease*†
Adrenal Pathology Lesion
Side
Laparoscopic
Approach‡
Previous
Abdominal
Surgery
Surgical
Time
(Minutes)
Blood
Loss
(mL)
Hospital Stay
(Days)
Size of
Adrenal
(cm)
Adrenal adenoma Right TA No 210 400 2 4.0
Cushing’s Adrenal adenoma Left TA Yes 190 100 4 5.9
Adrenal adenoma Right TA No 107 300 2 2.0
Adrenocortical carcinoma Right TA Yes 200 300 4 4.5
Adrenal adenoma Left TA No 200 100 21§ 7.0
Aldosteronoma Right TA No 100 30 2 1.0
Aldosteronoma Right TA No 465 100 2 2.8
Adrenal adenoma Right TA No 155 50 1 6.0
Aldosteronoma Right TR No 245 100 1 2.0
Cortical nodular hyperplasia Left TR Yes 217 50 1 4.0
*All patients were disease free at follow-up.
†There were no conversions to open surgery.
‡TA: Transabdominal, TR: Transretroperitoneal.
§Due to atrial fibrillation.
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astatic disease was successfully completed with difficulty
(6.5-cm mass, 315 minutes) (Table 2). In the second case,
laparoscopic resection of bilateral metastatic disease was
converted to open surgery because the left adrenal was
densely adherent to the pancreas and aorta. Similarly, the
right adrenal was adherent to the inferior vena cava.
Ultimately, both glands were removed with difficulty. In
the third case, a preoperative CT scan showed a 7-cm
mass within the right adrenal gland. However, intraoper-
atively, the tumor was found adherent to the liver and
inferior vena cava, and it proved to be unresectable. In
Group II, overall surgery time was 332 minutes, with an
average tumor size of 7.3 cm, blood loss of 233 mL, and
median hospital stay of 2 days. No complications occurred
in this group of patients. Table 3 compares the mean
objective findings of the 2 groups.
DISCUSSION
Metastasis to the adrenal gland is relatively common for
patients with bronchogenic carcinoma, melanoma, and
renal cell carcinoma.7,9–12 The adrenal gland has the great-
est rate of metastasis for any organ on a per-gram basis.8
With improved radiological techniques in CT and MRI,
coupled with percutaneous adrenal biopsies, diagnosis of
metastatic lesions to the adrenal is being made more
often.15 Prognoses for patients with widely metastatic dis-
ease from these cancers is dismal with few reports of
survival greater than 5 years.10,11,16 The discovery of iso-
lated metastasis to the adrenal gland is uncommon, and
although the survival benefit for patients undergoing re-
section is not clear, over the last 15 years, treatment
philosophy has changed from one of palliation to one of
aggressive surgical removal. In a large series of 37 patients
at Memorial-Sloan Kettering, Kim et al10 found a survival
benefit to surgical resection of solitary adrenal metastasis
as opposed to chemotherapy and radiation alone. Paul et
al11 found similar results with a median survival of 23
months in 77 patients. In their study, tumor size was
unrelated to survival, but patients with a longer disease-
free interval from time of primary cancer therapy to adre-
nal metastasis had a longer postoperative survival after
adrenalectomy. For patients undergoing adrenalectomy
for isolated metastasis, 5-year survival rates may approach
20% to 45%.11 Findings of other groups support these
results.16–19
The following inclusion criteria should be met when con-
sidering adrenal surgery for metastatic disease: (1) bio-
chemical evaluation is performed and addressed appro-
priately, (2) the patient has a biopsy-proven adrenal
metastasis that appears resectable on imaging studies, (3)
no evidence is present of distant metastasis, and (4) the
patient’s overall health warrants an aggressive approach.
Adrenal biopsy has a major complication rate of 0% to
9%.20,21 In 177 biopsies of patients with known extraad-
renal metastasis, De Augustin et al20 found 28% nondiag-
nostic (unsatisfactory sample), 33% metastatic consistent
Table 2.
Group II. Laparoscopic Adrenalectomy for Metastatic Disease*
Adrenal Pathology Lesion
Side
Laparoscopic
Approach‡
Surgical
Time
(Minutes)
Blood
Loss
(mL)
Hospital
Stay
(Days)
Size of
Adrenal
(cm)
Follow-up
(20–48 mos)
Conversion
to Open
Metastatic lung carcinoma Left TA 315 100 2 6.5 Alive with
recurrent disease
No
Metastatic lung carcinoma Bilateral TA 530 500 10 8.0, 7.0 Disease free Yes
Metastatic lung carcinoma Left TA 185 100 2 NR – Yes
*TA: Transabdominal; NR: Not resectable.
*All patients in Group II had had previous abdominal surgery.
Table 3.
Comparison of Group I and II
Group I
(Mean)
Group II
(Mean)
Tumor Size (cm) 2.6 7.3
Surgical time (minutes) 218 332
Blood loss (mL) 153 233
Median hospital stay 2 2
Complications Posthypokalemia,
New onset
atrial fibrillation
None
Conversion to open surgery None 75%
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25% with a negative biopsy (satisfactory sample with neg-
ative result). None of the patients with a negative biopsy
developed metastatic disease to the adrenal gland at fol-
low-up, while no comment was made about the patients
with a nondiagnostic biopsy.20 The overall nondiagnostic
biopsy rate for these patients according to Silverman et21
al in 101 biopsies was 18%. It has been recommended that
patients with a known primary cancer and adrenal mass
with a nondiagnostic biopsy should undergo rebiopsy or
surgery.11
Laparoscopic adrenalectomy for benign disease has been
shown in several studies1,5,6,9,14,22 to be efficacious with
decreased postoperative pain, shorter hospital stay, de-
creased blood loss, earlier ambulation, and earlier return
to normal function when compared to open surgery.
Laparoscopic adrenalectomy has been performed effec-
tively with both transperitoneal and retroperitoneal ap-
proaches. We have found that laparoscopic adrenalec-
tomy for benign disease in our patients was equally
effective and comparable to that in published series with
no major complications.5,22
At the same time, we encountered 2 major difficulties
intraoperatively in patients with metastatic disease. One,
we encountered inoperability due to local invasion of
surrounding structures. In one patient, the adrenal was
adherent to both the liver and inferior vena cava even
though preoperative CT did not suggest invasion of sur-
rounding structures. Preoperative CT suggested a tumor
size of 6.5 cm. As discussed previously, CT and MRI are
not always reliable for determining whether the tumor is
invasive. In another patient, the left adrenal was densely
adherent to the pancreas and aorta with a preoperative CT
interpretation of an 8.0-cm noninvasive mass on the left
side. The patient underwent conversion with a difficult en
bloc resection of this tumor and removal of the right
adrenal that was also densely adherent to the inferior vena
cava. Another patient proved to be unresectable despite
conversion with a favorable preoperative CT scan suggest-
ing no invasion. Our second difficulty encountered was
loss of fat planes. The adrenal gland is a friable organ, and
a key principle leading to successful en bloc removal of
the gland requires mobilization of the entire gland within
its periadrenal fat. All of our patients with metastatic dis-
ease had an inflammatory reaction caused by the tumor,
which made the dissection very tedious with distorted
anatomy. Others4,14,23,24 also describe their experience in
both open and laparoscopic adrenal surgery for metastatic
lesions with a “periadrenal” reaction associated with ill-
defined dissection planes. None of our patients with benign
disease demonstrated a periadrenal inflammatory reaction.
Few reports exist in the literature concerning laparoscopic
adrenalectomy for metastatic disease (Table 4). Suzuki14
reports the successful laparoscopic removal of a 4.5-cm
left adrenal for metastatic renal cell carcinoma, but Suzuki
also describes the need to convert a 5.5-cm left adrenal for
metastatic disease due to dense adhesions. Beninelli et
al25 describe successful laparoscopic removal of 6 adrenal
tumors in patients with non-small cell lung carcinoma.
Four patients had metastatic disease with tumor size rang-
ing from 2.8 cm to 4.7 cm in size. The other 2 tumors
proved to be nonfunctioning adrenal adenomas. They
also describe in their discussion of the 94 attempted adre-
nals removed laparoscopically that 2 were for colon me-
tastasis to the adrenal, which were abandoned secondary
to intraabdominal spread on the basis of laparoscopic
examination. Therefore, 4 of 6 metastatic lesions were
removed laparoscopically, all with tumor size less than 5
cm.25 Henry et al23 describe their laparoscopic experience
with successful removal of 44 of 48 large tumors less than
12 cm. Four tumors were metastatic lesions and treatment
for 3 of the 4 metastatic tumors was converted to open
surgery. None of their patients underwent preoperative
percutaneous adrenal biopsy, but in all of the metastatic
Table 4.
Published Experience With Laparoscopic Adrenalectomy for Solitary Metastasis
References Attempted Lap
Adrenalectomies
Successful Lap
Adrenalectomies
Mean Tumor
Size (cm)
Tumor Size
Range (cm)
Success
Rate
Bennili23 6 4 3.4 2.8–4.7 66%
Suzuki14 2 1 5.0 4.5–5.5 50%
Henry21 4 1 5.1 3.5–11.0 25%
Heinford4 10 9 5.9 1.8–12 90%
Current series 4 1 7.2 6.5–8.0 25%
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with dense adhesions. Heinford et al4 describe successful
laparoscopic removal of adrenal tumors for metastatic
disease in 9 of 10 patients with an average-tumor size of
5.9 cm. Combining our experience with that in the litera-
ture demonstrates that 16 of 25 (64%) metastatic cases
were successfully removed laparoscopically. Only 40% of
masses greater than 5 cm were successfully removed lapa-
roscopically. Laparoscopic adrenalectomy success rate for
benign disease, however, is greater than 95% overall.1,5,6,9,22
Our average tumor size was 7.3 cm, with Bennili’s group
removing all tumors less than 5 cm, and Heinfold’s group
averaging 5.9 cm. It is probable that the larger the tumor,
the more likely it is to be both invasive and to incite a
periadrenal reaction that makes the dissection extremely
difficult. Based on our experience and a review of the
literature, we believe that metastatic adrenal masses
greater than 5 cm have a high likelihood of open conver-
sion, or at the very least, a long and difficult dissection.
CONCLUSION
Laparoscopic adrenalectomy for benign disease is an ex-
tremely successful method for removing these tumors
with a greater than 95% success rate. At the same time,
laparoscopic adrenalectomy for solitary metastasis cou-
pled with meticulous preoperative evaluation has an over-
all success rate of 64%. For tumors greater than 5 cm, that
success rate drops to less than 40%. We conclude that
laparoscopic adrenalectomy for metastatic disease is less
likely to be completed successfully for tumors of a similar
size when compared with those of a benign origin. We
encountered 2 difficulties specific to metastatic lesions,
loss of fat planes and an inability to preoperatively predict
the invasive nature of the tumor. We do not believe that
isolated metastasis to the adrenal gland is a contraindica-
tion to laparoscopic surgery, but experienced surgeons
who commit to the laparoscopic approach must be aware
of the high conversion and failure rate. Further data need
to be collected to determine the role of laparoscopic
adrenalectomy for metastatic lesions.
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